Zdrowie i gospodarka · 11/03/1994
Opportunity for a License: Assay Using Recombinant Histidyl-tRNA Synthetase
The National Institutes of Health seeks to license a novel assay to detect auto-antibodies to histydyl tRNA synthetase, known as JO1, with increased sensitivity for diagnosing autoimmune diseases such as myositis, polymyositis, and dermatomyositis.